Leo has stated in the past that P was the most uncertain of $CTIX products. I personally felt it had a 50/50 chance of clinical success. I was pleasantly surprised to see yesterday's positive PR after seeing that the stock was down. Every time $CTIX chalks up another clinical success they "move the ball closer to the goal-line" for all of us longs. $CTIX is batting 100% which is something I have never seen before in a small biotech. I have been invested since 2011 primarily for K. As big of a success that I believe K will be, I think B and P are going to make all of the longs major coin well before K is in a phase3 trial. It will be fun to be sitting on $20-$30/shares waiting for the monster payday of K.